FibroGen, Inc. (FGEN)

$0.40 -3.85% $-0.02 Healthcare

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

$40.16M

Mr. Enrique A. Conterno

566.00

San Francisco, CA

Nov 14, 2014

-0.24

$-1.70

0.95

1.41

-96.84%

-0.25

-0.00

-0.18

0.24

1.24

-57.41%

81.93%

Similar stocks (19)

Vaxcyte, Inc.

PCVX

$115.14 -1.69%
Uptrend

BioMarin Pharmaceutical Inc.

BMRN

$70.34 -1.49%
Downtrend

Revolution Medicines, Inc.

RVMD

$45.64 -1.18%
Uptrend

Blueprint Medicines Corporation

BPMC

$91.99 1.15%
Downtrend

Agios Pharmaceuticals, Inc.

AGIO

$47.08 -0.64%
Uptrend

Akero Therapeutics, Inc.

AKRO

$27.76 -0.86%
Uptrend

Syndax Pharmaceuticals, Inc.

SNDX

$18.55 -0.43%
Downtrend

Ardelyx, Inc.

ARDX

$6.16 2.84%
Downtrend

Day One Biopharmaceuticals, Inc.

DAWN

$14.72 2.83%
Downtrend

Cullinan Oncology, Inc.

CGEM

$18.11 0.95%
Downtrend

Stoke Therapeutics, Inc.

STOK

$14.22 -6.11%
Uptrend

Larimar Therapeutics, Inc.

LRMR

$7.04 -1.40%
Downtrend

Monte Rosa Therapeutics, Inc.

GLUE

$6.71 7.40%
Neutral

Lyell Immunopharma, Inc.

LYEL

$1.58 0.96%
Downtrend

Sutro Biopharma, Inc.

STRO

$3.91 -0.26%
Downtrend

Biomea Fusion, Inc.

BMEA

$8.70 -0.11%
Downtrend

Gossamer Bio, Inc.

GOSS

$1.05 9.40%
Downtrend

Verastem, Inc.

VSTM

$2.97 4.95%
Downtrend

Hepion Pharmaceuticals, Inc.

HEPA

$0.70 1.98%
Downtrend

ETF Exposure (24)

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.169%

$27.63 0.44%
Uptrend

Vanguard Strategic Small-Cap Equity Fund Investor Shares

VSTCX

0.05%

$42.94 2.14%
Uptrend

FlexShares Morningstar Emerging Markets Factor Tilt Index Fund

TLTE

0.0203%

$54.49 -0.05%
Uptrend

Vanguard Capital Opportunity Fund

VHCAX

0.02%

$202.61 1.94%
Uptrend

Vanguard Capital Opportunity Fund Investor Shares

VHCOX

0.02%

$87.76 1.94%
Uptrend

SPDR S&P Emerging Markets Small Cap ETF

EWX

0.012365%

$59.18 -0.27%
Uptrend

iShares Micro-Cap ETF

IWC

0.01118%

$125.35 -0.94%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Health Care Index Fund

VHT

0%

$285.02 -0.50%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Horizon Funds - Vanguard Strategic Equity Fund

VSEQX

0%

$39.87 1.84%
Uptrend

Vanguard FTSE All-World ex-US Small Capital Index Fund

VSS

0%

$123.11 -0.73%
Uptrend

Vanguard Total World Stock Index Fund

VT

0%

$117.86 -0.41%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$281.23 -0.29%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Total Intl Stock Idx Fund

VTSNX

0%

$137.10 2.05%
Uptrend

Vanguard Emerging Markets Stock Index Fund

VWO

0%

$45.34 0.04%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$181.72 -0.66%
Uptrend

Vanguard Total Intl Stock Idx Fund

VXUS

0%

$63.13 -0.63%
Uptrend